Adaptive Biotechnologies
Bryan J. Kennedy is a skilled Flow Cytometry Specialist in the Antigen Map division at Adaptive Biotechnologies Corp. since May 2019. Prior experience includes roles as an Analytical Development/QC Analyst at Fred Hutch, where Bryan developed and optimized multicolor flow cytometry assays, and as a Scientist at Bristol-Myers Squibb, focusing on immune monitoring and characterizing immune cells. Bryan's career began at the University of Washington, progressing from Research Scientist positions in various departments to Senior Associate Scientist at Amgen, where Bryan contributed to multiple therapeutic areas through flow cytometric analysis and cell-based functional assays. Bryan's educational background includes a Certificate in Clinical Trials Research from the University of Washington and a BS in Microbiology with an emphasis on Immunology from Washington State University.
This person is not in the org chart
This person is not in any teams
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.